Who
Andrew Lawrence Taylor
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Orchestra BioMed Holdings; Chief Financial Officer, Motus GI Holdings.
In numbers
- Trades disclosed
- 36
- Buys
- 6
- Sells
- 0
- Bought
- $25K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 16 Feb 2018
- Last trade
- 26 Aug 2026
- Last filed
- 28 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Aug 2026filed 28 Aug 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $16K3,076 at $5.26 | filing |
| 26 Aug 2026filed 28 Aug 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $16K3,076 at $5.26 | filing |
| 10 Jun 2026filed 12 Jun 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $146K36,352 at $4.02 | filing |
| 10 Jun 2026filed 12 Jun 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $146K36,352 at $4.02 | filing |
| 28 May 2026filed 29 May 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $12K3,076 at $3.98 | filing |
| 28 May 2026filed 29 May 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $12K3,076 at $3.98 | filing |
| 12 Feb 2026filed 13 Feb 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code A | —181,000 at $0.00 | filing |
| 12 Feb 2026filed 13 Feb 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code A | —181,000 at $0.00 | filing |
| 2 Jan 2026filed 2 Jan 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $15K3,452 at $4.31 | filing |
| 2 Jan 2026filed 2 Jan 2026 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $15K3,452 at $4.31 | filing |
| 10 Dec 2025filed 12 Dec 2025 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $40K8,670 at $4.67 | filing |
| 25 Nov 2025filed 26 Nov 2025 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $16K3,071 at $5.35 | filing |
| 17 Sep 2025filed 19 Sep 2025 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $40K16,102 at $2.46 | filing |
| 25 Aug 2025filed 25 Aug 2025 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Bought | $5,1002,000 at $2.55 | filing |
| 7 Aug 2025filed 8 Aug 2025 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code A | —80,000 at $0.00 | filing |
| 11 Jun 2025filed 13 Jun 2025 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $88K28,172 at $3.14 | filing |
| 4 Apr 2025filed 4 Apr 2025 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code A | —84,000 at $0.00 | filing |
| 19 Dec 2024filed 20 Dec 2024 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Bought | $4,8301,000 at $4.83 | filing |
| 12 Dec 2024filed 13 Dec 2024 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code F | $173K34,403 at $5.03 | filing |
| 8 May 2024filed 10 May 2024 | OBIO Orchestra BioMed HoldingsMedical Devices | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
News
Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SABOBIO · manilatimes.net · 22 Oct 2026
0 headlines in the last 90 days name Andrew Lawrence Taylor; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.